NCT06109558
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Hunan Cancer Hospital Changsha, Hunan, China
Clinical trial condition
EGF-R Positive Non-Small Cell Lung Cancer
Explore clinical trials studying EGF-R Positive Non-Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.
10 public trials
2 recruiting studies
EGF-R Positive Non-Small Cell Lung Cancer trial results
NCT05033691
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +18 more
- Locations
-
- Hadassah Ein Kerem Medical Center Jerusalem, Israel
Not Yet Recruiting
CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC
NCT06557096
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
- Locations
-
Not specified
Not Yet Recruiting
The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC
NCT06287593
- Conditions
- EGF-R Positive Non-Small Cell Lung Cancer
- Locations
-
Not specified
Not Yet Recruiting
Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO)
NCT05998993
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
- CTIC - Centro de Tratamiento e Investigación Sobre Cáncer Luis Carlos Sarmiento Angulo Bogotá, Colombia
Not Yet Recruiting
Neoadjuvant Icotinib With Chemotherapy for Epidermal Growth Factor Receptor(EGFR)-Mutated Resectable Lung Adenocarcinoma
NCT05132985
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Liaoning Cancer Hospital & Institute Shenyang, Liaoning, China
NCT04965701
- Conditions
- EGF-R Positive Non-Small Cell Lung Cancer
- Locations
-
- Istituto Oncologico Veneto Padova, Italy
NCT04640870
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
Not specified
Active, Not Recruiting
Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations
NCT05256290
- Conditions
- Advanced Lung Carcinoma, Advanced Non-Small Cell Squamous Lung Cancer, Brain Diseases, +23 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- City of Hope Huntington Beach Huntington Beach, California, United States
- City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
Active, Not Recruiting
Dacomitinib in Lung Cancer With Uncommon EGFR Mutations
NCT04504071
- Conditions
- EGF-R Positive Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer Metastatic
- Locations
-
- Shanghai Chest hospital Shanghai, Shanghai Municipality, China